EUVIMEDEUVIMED entdecken
Crossref

Dihydrotanshinone I Attenuates Atherosclerosis via Inhibiting NLRP3 Inflammasome Activation and Modulating Gut Microbiota

Haozhen Li, Chengyi Ban, Jiasen An, Jianhang Yang, Jinzhao Ren, Yuhang Wu, Zenan Shen, Jiandong Zhang, Xiaolong Gu, Hongbin Liu

Biological and Pharmaceutical Bulletin · 23.07.2026 · 49 (7) · 1140-1152

DOI: 10.1248/bpb.b26-00124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, erschienen am 23.07.2026. Verfasst von Haozhen Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hebei North University, Zhangjiakou 075000, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Atherosclerosis, Inflammasomes, Gastrointestinal Microbiome. Die Arbeit nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinAtherosclerosisInflammasomesGastrointestinal MicrobiomePhenanthrenesAnti-Inflammatory AgentsQuinonesAnimalsMaleMice, Inbred C57BLMiceDiet, High-FatSalvia miltiorrhizaHumansFurans

Stichwörter der Autor:innen

NOD-, LRR-, and pyrin domain-containing protein 3 inflammasomeatherosclerosisdihydrotanshinone Igut microbiota

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesPhenanthrenesdihydrotanshinone INlrp3 protein, mouseAnti-Inflammatory AgentsQuinonesFurans

Autor:innen und Institutionen

  • School of Pharmacy, Hebei North University, Zhangjiakou 075000, China.
  • College of Animal Science and Technology, Hebei North University, Zhangjiakou 075000, China.
  • Hebei Key Laboratory of Neuropharmacology, Zhangjiakou 075000, China.

Zitieren

APA

Li, H., Ban, C., An, J., Yang, J., Ren, J., Wu, Y., Shen, Z., Zhang, J., Gu, X., & Liu, H. (2026). Dihydrotanshinone I Attenuates Atherosclerosis via Inhibiting NLRP3 Inflammasome Activation and Modulating Gut Microbiota. Biological and Pharmaceutical Bulletin, 49(7), 1140-1152. https://doi.org/10.1248/bpb.b26-00124

Vancouver

Li H, Ban C, An J, Yang J, Ren J, Wu Y, et al. Dihydrotanshinone I Attenuates Atherosclerosis via Inhibiting NLRP3 Inflammasome Activation and Modulating Gut Microbiota. Biological and Pharmaceutical Bulletin. 2026;49(7):1140-1152. doi:10.1248/bpb.b26-00124

BibTeX
@article{Li2026,
  author = {Li, Haozhen and Ban, Chengyi and An, Jiasen and Yang, Jianhang and Ren, Jinzhao and Wu, Yuhang and Shen, Zenan and Zhang, Jiandong and Gu, Xiaolong and Liu, Hongbin},
  title = {Dihydrotanshinone I Attenuates Atherosclerosis via Inhibiting NLRP3 Inflammasome Activation and Modulating Gut Microbiota},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2026},
  volume = {49},
  number = {7},
  pages = {1140--1152},
  doi = {10.1248/bpb.b26-00124}
}
Kostenlos starten →